Login

A Survey Of Aerospace Industry Inventor Incentive Awards

Henry FradkinValue Extraction LLC, Principal, Dearborn, MI, USA Allen VaughnLockheed Martin Manager, IP Strategy & Licensing, Dallas, TX, USA The Aerospace and Transportation Committee of LES (USA & Canada) was founded in 1998 to provide member companies an opportunity to network and exchange best practices for those involved heavily in manufacturing goods and products. As […]

Assuring All Substantial Rights In Exclusive Patent Licenses

Jeffrey L. NewtonAvago Technologies, Intellectual Property Attorney, Fort Collins, CO, USA Introduction Despite their best of intentions, parties draft license agreements which purport to have the patentee grant sufficient rights for a licensee to assert a patent against third parties, but fail to grant all substantial rights to sue. The surprising number of cases decided […]

WIPO Domain Name Cases Offer Trademark Licensing Lessons

Hee-Eun KimMunich IP Law Center, Max Planck Inst. For IP, Competition & Tax Law, LLM Student, Munich, Germany 1. The Uniform Domain Name Dispute Resolution Policy Avoiding jurisdictional and cost problems associated with the court system, the Uniform Domain Name Dispute Resolution Policy (UDRP), adopted by ICANN at the initiative and with the assistance of […]

The Valuation Of Drug Development Projects—Part 2

Sangeeta PuranMayer Brown International, Senior Associate, London, UK Earlier in March, the author completed a study examining the methods used to value drug development projects. The study was conducted by interviewing individuals over a period of four months in the UK from a representative sample of twelve leading industry participants, including small biotech business development […]

The Inclusion Of Back-Up Compounds In Pharmaceutical Licensing Agreements

David ScottPharmaConsulting, Licensing & Business Development Consultant Loughborough, England Increasingly, before taking on new inward licensing opportunities, pharmaceutical companies are seeking to identify and include back-up compounds, so as to reduce he risk if the lead compound fails in development. As a result, many of the major companies, such as Astra-Zeneca, now explicitly include the […]

Recent U.S. Decisions And Developments Affecting Licensing – March 2010

Brian BrunsvoldFinnegan, Henderson, Farabow, Garrett & Dunner, LLP, Attorney, Washington, D.C., USA John C. PaulFinnegan, Henderson, Farabow, Garrett & Dunner, LLP, Attorney, Washington, D.C., USA UNIVERSITY DOES NOT OBTAIN TITLE TO AN INVENTION FROM A RESEARCHER WHO AGREES TO ASSIGN HIS INVENTION TO THE UNIVERSITY, AND WHO LATER ASSIGNS HIS INVENTIONS TO A THIRD PARTY […]

How Much Should You Invest In Patents?

Kelce WilsonResearch In Motion, Senior Patent Attorney, Dallas, TX, USA Claudia Tapia GarciaRIM Ltd, IPR Counsel, Munich, Germany Setting a budget for intellectual property (IP) protection, including patent prosecution, enforcement and acquisition, can be a complex task, full of uncertainty and often subject to random criteria. Should you spend more, spend less, or keep things […]

Do We See The Emergence Of “Patent Left”?

Guillaume MénageFrance Telecom, Senior Intellectual Property Counsel, Paris, France Yann DietrichAreva T&D, Intellectual Property Legal Director, Paris, France Mark Chandler, General Counsel of Cisco, indicated in his recent testimony to the United States Congress that “a recent survey of leading technology companies shows that since 2004, licensing requests have increased approximately 650 percent.” He added […]

Search LESI

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors